Armando Giuliano
Overview
Explore the profile of Armando Giuliano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1087
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Partridge A, Hyslop T, Rosenberg S, Bennett A, Drier S, Jonsson M, et al.
JAMA Oncol
. 2024 Dec;
PMID: 39665588
Importance: Active monitoring (AM) for low-risk ductal carcinoma in situ (DCIS) has been considered as a potential alternative to guideline-concordant care (GCC; inclusive of surgery with or without radiation). Reported...
2.
Hwang E, Hyslop T, Lynch T, Ryser M, Weiss A, Wolf A, et al.
JAMA
. 2024 Dec;
PMID: 39665585
Importance: Active monitoring for low-risk ductal carcinoma in situ (DCIS) of the breast has been proposed as an alternative to guideline-concordant care, but the safety of this approach is unknown....
3.
Weed C, Wang T, Mohan S, Wang X, Tseng J, Hu T, et al.
Clin Breast Cancer
. 2024 Apr;
24(5):457-462.
PMID: 38609794
Background: Nipple sparing mastectomy (NSM) is increasingly being performed for patients with breast cancer. However, optimal postoperative surveillance has not been defined. Methods: A prospectively maintained database identified patients with...
4.
Manguso N, Kim M, Joshi N, Mahmud M, Aldaco J, Suzuki R, et al.
NAR Cancer
. 2024 Apr;
6(2):zcae016.
PMID: 38596431
With its ligand estrogen, the estrogen receptor (ER) initiates a global transcriptional program, promoting cell growth. This process involves topoisomerase 2 (TOP2), a key protein in resolving topological issues during...
5.
Tanaka H, Murata M, Igari F, Urbanowicz R, Mouakkad L, Kim S, et al.
Res Sq
. 2024 Jan;
PMID: 38260372
Interrogating plasma cell-free DNA (cfDNA) to detect cancer offers promise; however, no current tests scan structural variants (SVs) throughout the genome. Here, we report a simple molecular workflow to enrich...
6.
Shiao S, Gouin 3rd K, Ing N, Ho A, Basho R, Shah A, et al.
Cancer Cell
. 2024 Jan;
42(1):70-84.e8.
PMID: 38194915
Strategies are needed to better identify patients that will benefit from immunotherapy alone or who may require additional therapies like chemotherapy or radiotherapy to overcome resistance. Here we employ single-cell...
7.
Liu Y, Chen S, Tian M, Giuliano A, Cui X
MedComm (2020)
. 2023 Dec;
4(6):e440.
PMID: 38107056
No abstract available.
8.
Chaum M, Grossi S, Chen J, Hu V, Ray E, Giuliano A, et al.
Breast
. 2023 Nov;
72:103596.
PMID: 37951051
Purpose: Almost two percent of individuals in the United States identify as gender non-conforming. In the female-to-male (FTM) transgender population, masculinizing hormone therapy with testosterone is commonly prescribed in gender...
9.
Are C, Murthy S, Sullivan R, Schissel M, Chowdhury S, Alatise O, et al.
Lancet Oncol
. 2023 Nov;
24(12):e472-e518.
PMID: 37924819
The first Lancet Oncology Commission on Global Cancer Surgery was published in 2015 and serves as a landmark paper in the field of cancer surgery. The Commission highlighted the burden...
10.
Weed C, Wang T, Fat S, Chung A, Boyle M, Giuliano A, et al.
Ann Surg Oncol
. 2023 Jun;
30(9):5335-5336.
PMID: 37358679
No abstract available.